Form 4 for AORT ARTIVION, INC.
Accepted 2025-06-18 00:00:00 ET · period of report 2025-06-17 · accession 0000784199-25-000133 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-06-18 | 2025-06-17 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $29.50 | -15.0K | 64.2K | -19% | -$442.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-17 | S | D | 13,764 | $29.50 | 65,436 | D | — | — | (F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2025. (F2) Reflects the price the shares were sold. |
| 2 | Common | Common Stock | 2025-06-17 | S | D | 1,236 | $29.50 | 64,200 | D | — | — | (F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2025. (F2) Reflects the price the shares were sold. |